| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/11/2012 | CN102552941A Two-nuclear magnetic resonance imaging contrast agent taking 2,5-dimethylpyrazine as connector and preparation method of two-nuclear magnetic resonance imaging contrast agent |
| 07/11/2012 | CN102552940A Microwave-assisted method for preparing magnetic resonance imaging contrast agent |
| 07/11/2012 | CN102552939A Targeting PLGA (poly(lactic-co-glycolic acid)) fluorescence probe coated with methylene blue and the preparation method thereof |
| 07/11/2012 | CN102552933A 蛋氨酸酶在抗蛋氨酸和抗高半胱氨酸的化学治疗中的应用 Methioninase used in chemotherapy anti-methionine and homocysteine in the anti- |
| 07/11/2012 | CN102552929A Method for enhancing targeting selectivity of administration system by modifying cell penetrating peptide |
| 07/11/2012 | CN102552145A Preparation method of artificial liposome |
| 07/11/2012 | CN102552105A Cascade brain-targeting drug delivery system as well as preparation method and application thereof |
| 07/11/2012 | CN102551910A Method for establishing rhesus monkey senile dementia model and medicine screening method |
| 07/11/2012 | CN102133409B Sterilizing type medical ultrasonic coupling agent and preparation method thereof |
| 07/11/2012 | CN101563107B Radioactive diagnostic imaging agent |
| 07/11/2012 | CN101401728B Construction method for digitized virtual hand and longitudinal shaped severed finger anatomic structure model |
| 07/10/2012 | US8219182 Cavity-filling biopsy site markers |
| 07/10/2012 | US8217293 Process and system for producing nuclear spin polarized xenon gas |
| 07/10/2012 | US8217012 Peptides for targeting apoptotic cells and uses thereof |
| 07/10/2012 | US8216795 Tuberculosis diagnostic test |
| 07/10/2012 | US8216563 Methods of determining efficacy of treatments of diseases of the bowel |
| 07/10/2012 | US8216551 In vivo system to monitor tissue responses in birds |
| 07/10/2012 | US8216549 Method for making a ligand-quantum dot conjugate |
| 07/10/2012 | CA2211324C Recombinant human alpha-fetoprotein and uses thereof |
| 07/05/2012 | WO2012091606A1 Improved glycan arrays and methods for their fabrication |
| 07/05/2012 | WO2012091518A2 Phospholipid nanoparticles for mr-induced high-intensity focused ultrasonic treatment and diagnosis, and method for producing same |
| 07/05/2012 | WO2012091452A2 Biocompatible agent for dispersing nanoparticles into an aqueous medium using mussel adhesive protein-mimetic polymer |
| 07/05/2012 | WO2012090895A1 Monoclonal antibody capable of recognizing human papilloma virus (hpv) l2 protein, and method for measuring hpv-neutralizing antibody titer using same |
| 07/05/2012 | WO2012048335A3 Formulation of acoustically activatable particles having low vaporization energy and methods for using same |
| 07/05/2012 | WO2012021046A9 Radial shape of polymer compound containing iodine, preparation method thereof, and ct contrast medium composition containing same |
| 07/05/2012 | US20120174240 Role of proteoglycans in drug dependence |
| 07/05/2012 | US20120172227 5-aminolevulinic acid salt, process for producing the same and use thereof |
| 07/05/2012 | US20120171690 Transgenic Animals for Analyzing CYP3A4 Cytochrome P450 Gene Regulation |
| 07/05/2012 | US20120171248 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/05/2012 | US20120171125 Methods for Enhancing the Cognitive Function |
| 07/05/2012 | US20120171124 Screening methods for cognitive enhancers |
| 07/05/2012 | US20120171123 Uses and compositions for treatment of rheumatoid arthritis |
| 07/05/2012 | US20120171122 Loop-Variant Pdz Domains As Biotherapeutics, Diagnostics And Research Reagents |
| 07/05/2012 | US20120171121 Rosette Nanotubes as Drug Delivery Agents |
| 07/05/2012 | US20120171120 Low affinity blood brain barrier receptor antibodies and uses therefor |
| 07/05/2012 | US20120171116 Arginase Inhibitors and Methods of Use Thereof |
| 07/05/2012 | US20120171115 Immuno-conjugates and methods for producing them |
| 07/05/2012 | CA2823511A1 Improved glycan arrays and methods for their fabrication |
| 07/05/2012 | CA2819947A1 Monoclonal antibody recognizing human papillomavirus (hpv) l2 protein and method for measuring hpv-neutralizing antibody titer using the same |
| 07/04/2012 | EP2471556A1 Contrast agent for photoacoustic imaging and photoacoustic imaging method utilizing same |
| 07/04/2012 | EP2470218A2 Methods and compositions for treatment of pulmonary fibrotic disorders |
| 07/04/2012 | EP2249273B1 Systems and methods for managing information relating to medical fluids and containers therefor |
| 07/04/2012 | EP1914651B1 Systems and methods for managing information relating to medical fluids and containers therefor |
| 07/04/2012 | EP1880330B1 Systems and methods for managing information relating to medical fluids and containers therefor |
| 07/04/2012 | CN102548586A Hydroxylated contrast enhancement agents and intermediates thereof |
| 07/04/2012 | CN102548585A Magnetic resonance imaging contrast agent with paramagnetic-inositol phosphates complexes |
| 07/04/2012 | CN102548466A Non-invasive in vivo optical imaging method |
| 07/04/2012 | CN102533917A Method for preparing RGD (arginine glycine aspartate) active polypeptide from collagen |
| 07/04/2012 | CN102533661A Human embryonic stem cell-derived endothelial cell from with functions of tumor targeting, in-vivo tracking and tumor treating |
| 07/04/2012 | CN102533635A Method for labeling mouse embryonic stem cells by using fluorescent dyes, and application thereof |
| 07/04/2012 | CN102532264A Peptide-based compounds |
| 07/04/2012 | CN102532178A Fluorescent probe for detecting biologic thiol and preparation method and usage method thereof |
| 07/04/2012 | CN102532055A Benzothiazole derivative compounds, compositions and uses |
| 07/04/2012 | CN102526774A Capsules for displaying pathological changes in left adnexal area conveniently |
| 07/04/2012 | CN102526773A Chinese medicinal capsule for displaying duodenal ulcer of infants |
| 07/04/2012 | CN102526772A Chinese medicinal enteric capsule capable of indicating early-phase small intestinal exogenous tumor |
| 07/04/2012 | CN102526771A Invisible nano-liposome injection for encapsulating USPIO (Ultra-small Super Paramagnetic Iron Oxide) and preparation method and application thereof |
| 07/04/2012 | CN102526770A Aptamer target-based superparamagnetic iron oxide nanocomposite magnatic resonance imaging contrast agent |
| 07/04/2012 | CN102526769A CT/MRI dual-modality molecular imaging contrast agent and method for manufacturing the same |
| 07/04/2012 | CN102526768A Microvessel contrast agent based on nanometer level barium apatite and preparation method of microvessel contrast agent |
| 07/04/2012 | CN102526767A Transporting marker for gastrointestinal tract and preparation method thereof |
| 07/04/2012 | CN102526766A Naphthdianthrone compound and application of salt thereof in preparing developer of biliary tract and gall stones |
| 07/04/2012 | CN102526765A Abeta plaque developing agent and preparation method thereof |
| 07/04/2012 | CN102526764A Monkey severe generalized parkinsonism model and drug screening method thereof |
| 07/04/2012 | CN102526047A Model of monkey with chronic systemic Parkinson's disease and method for sieving medicament for treating chronic systemic Parkinson's disease |
| 07/04/2012 | CN102526034A Establishment of fulminant liver function failure model of rhesus |
| 07/04/2012 | CN102525936A Compound epirubicin hydrochloride polylactic-co-glycolic acid (PLGA) nanoparticles and preparation method thereof |
| 07/04/2012 | CN102525935A Brain delivery method for nano-medicament carrier |
| 07/04/2012 | CN102525882A Nanocomposite temperature-sensitive gel and preparation method and application thereof |
| 07/04/2012 | CN102525421A Detecting micro-needle with strengthened Raman and fluorescence signal and preparation method thereof |
| 07/04/2012 | CN102524178A Screening method of febrile convulsion model rat and application thereof |
| 07/04/2012 | CN102068706B Preparation method of silicon dioxide (SiO2) ultrasonic imaging radiography material |
| 07/04/2012 | CN101987201B Medical ultrasonic probe sterilizing gel and preparation method thereof |
| 07/04/2012 | CN101891897B Method for preparing paramagnetic polyphosphazene nanotube magnetic resonance imaging contrast agent |
| 07/04/2012 | CN101812528B Switch mode aptamer probe and application thereof in tumor living cell and vital detection |
| 07/04/2012 | CN101773676B Liquid fluorocarbon supported polymer nanometer ultrasonic imaging micelle and preparation method thereof |
| 07/04/2012 | CN101759804B Anti-human thyroglobulin monoclonal antibody and application thereof |
| 07/04/2012 | CN101628119B Dermatophagoides pteronyssinus (Der p) allergen diagnostic reagent and preparation method thereof |
| 07/04/2012 | CN101619106B Polysaccharide macromolecular paramagnetic metal complex and synthesis method and application thereof |
| 07/04/2012 | CN101607913B 改进的螯合剂缀合物 Improved chelator conjugate |
| 07/04/2012 | CN101554574B Superparamagnetism nano particle jointly modified by aminosilane coupling agent and hyskon and preparation method thereof |
| 07/04/2012 | CN101528268B Gas-filled microvesicles with polymer-modified lipids |
| 07/04/2012 | CN101410141B Diagnostic systems and methods utilizing probe-ions exhibiting photon avalanche effect |
| 07/04/2012 | CN101137398B Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications |
| 07/03/2012 | US8212004 Hybridoma cell for use in propagation of immunoglobulins for treatment and prevention of autoimmune, pancreatic, blood and cell proliferative disorders |
| 07/03/2012 | US8211660 In-vivo monitoring of circulating apoptotic cells |
| 07/03/2012 | US8211404 Ionic and non-ionic radiograhic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics |
| 07/03/2012 | US8211402 CA-IX specific radiopharmaceuticals for the treatment and imaging of cancer |
| 07/03/2012 | US8211401 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA |
| 07/03/2012 | CA2403001C Modulating production of pneumococcal capsular polysaccharide |
| 07/03/2012 | CA2397610C In vivo assay for testing the phenotypic stability |
| 06/28/2012 | WO2012088434A2 Compositions relating to a phosphoprotein and methods of use |
| 06/28/2012 | WO2012087040A2 Conjugate for photodynamic diagnosis or therapy and method for preparing same |
| 06/28/2012 | WO2012085789A1 Agents for clearing biomolecules from circulation |
| 06/28/2012 | WO2012085751A1 Photo-acoustic signal enhancement with microbubble-based contrast agents |
| 06/28/2012 | WO2012084981A1 Chelate nanoemulsion for mri |
| 06/28/2012 | WO2012084926A1 Desalination of a composition comprising a contrast agent |
| 06/28/2012 | WO2012084228A1 Biodegradable contrast agents |
| 06/28/2012 | WO2012083532A1 Method for ultrasound controlled releasing medicine-carrying contrast micro-bubbles and monitor-imaging thereof and method for estimating damaged quantity of microbubbles |
| 06/28/2012 | WO2012054717A3 Detecting and treating solid tumors through selective disruption of tumor vasculature |